Oncolytics Biotech Inc 将开会讨论Pelareorep在二线及后线SCAC中的单臂关键研究

美股速递
Apr 06

Oncolytics Biotech Inc 宣布将召开会议,重点讨论其候选药物Pelareorep在二线及后线转移性结直肠腺癌(SCAC)患者中进行的单臂关键性研究。该研究旨在评估Pelareorep在这一难治患者群体中的疗效与安全性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10